Eczema therapeutics in children: what do the clinical trials say?

Theresa N H Leung1, K L Hon1

  • 1Department of Paediatrics, The Chinese University of Hong Kong, 6/F, Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong.

Insights

Eczema, or atopic dermatitis, is a chronic childhood condition with no cure. Management focuses on symptom variability, topical treatments, and avoiding triggers, with systemic options for severe cases.

Area of Science:

  • Dermatology
  • Allergology
  • Immunology

Background:

  • Eczema (atopic dermatitis) is a prevalent childhood atopic disease.
  • It is characterized by chronicity and significantly impairs quality of life.
  • Current treatments aim to manage symptoms as no cure exists.

Purpose of the Study:

  • To review current therapeutic strategies for eczema (atopic dermatitis).
  • To highlight the importance of individualized management approaches.
  • To discuss various treatment modalities, including basic, anti-inflammatory, and systemic therapies.

Main Methods:

  • Review of established and emerging treatments for atopic dermatitis.
  • Discussion of basic management principles: education, hydration, trigger avoidance.
  • Exploration of anti-inflammatory options: topical corticosteroids, calcineurin inhibitors.
  • Consideration of systemic immunosuppressants for refractory cases.
  • Inclusion of adjuvant therapies: UV irradiation, antimicrobial treatments.
  • Evaluation of specific interventions: dietary changes, allergen immunotherapy.
  • Mention of complementary and alternative medicine (CAM) in eczema management.

Main Results:

  • Treatment relies on topical and systemic anti-allergic or immunomodulating therapies.
  • Topical corticosteroids, macrolide immunosuppressants, and oral immunomodulating drugs are mainstays.
  • Basic therapy includes patient education, topical hydration, and trigger avoidance.
  • Anti-inflammatory treatments manage exacerbations and proactive therapy.
  • Systemic immunosuppression is for severe, refractory cases.
  • Microbial colonization may necessitate antimicrobial treatment.
  • UV irradiation (UVA1, narrowband UVB) serves as adjuvant therapy.
  • Dietary changes and allergen immunotherapy are indicated only when specific allergies are confirmed.
  • CAM use is popular but lacks robust evidence.

Conclusions:

  • Effective eczema management requires a personalized approach considering symptomatic variability.
  • A combination of basic care, anti-inflammatory treatments, and potentially systemic therapies is crucial.
  • Adjuvant therapies, specific dietary interventions, and immunotherapy have roles in select cases.
  • While CAM is utilized, evidence-based data are limited, necessitating caution.

Keywords:
ChildEczema

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
71
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K